复发性甲状腺髓样癌在68Ga-前列腺特异性膜抗原PET/CT上的表现:探索新的诊疗途径
为评估PSMA表达并探索治疗选择,行68Ga-PSMA-HBED-CC PET/CT,显示左侧甲状腺床软组织肿块及颈部淋巴结强烈PSMA摄取。
要点
- 甲状腺髓样癌复发患者中,68Ga-PSMA PET/CT显示左侧甲状腺床软组织肿块和颈部淋巴结强烈PSMA摄取。
- PSMA在甲状腺髓样癌中的表达为探索诊疗一体化途径提供了依据。
核心结论
- 复发性甲状腺髓样癌可表达PSMA,68Ga-PSMA PET/CT显示左侧甲状腺床软组织肿块和颈部淋巴结强烈摄取,提示可探索诊疗一体化途径。
研究设计与样本
- 病例报告:一名35岁男性甲状腺髓样癌患者,全甲状腺切除及双侧颈清扫后出现降钙素水平升高和局部颈部复发。
主要发现
- 68Ga-PSMA-HBED-CC PET/CT显示左侧甲状腺床软组织肿块和颈部淋巴结强烈PSMA摄取。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The prostate-specific membrane antigen (PSMA) is highly expressed in prostate cancer cells. Few other malignancies have shown expression of PSMA. We present a case of 35-year-old man with medullary thyroid carcinoma, post total thyroidectomy and bilateral neck dissection, now presenting with rising calcitonin levels (doubling time 9 months) and local neck recurrence with negative I-MIBG scan. We decided to perform Ga-PSMA-HBED-CC PET/CT scan to assess PSMA expression and explore the therapeutic option in view of rising serum calcitonin. It revealed intense PSMA uptake in the soft tissue mass in left thyroid bed and cervical lymph nodes.
引用
- Arora S, Damle NA, Parida GK, et al. Recurrent Medullary Thyroid Carcinoma on 68Ga-Prostate-Specific Membrane Antigen PET/CT: Exploring New Theranostic Avenues. Clin Nucl Med. 2018. PMID: 29485449. doi:10.1097/RLU.0000000000002010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。